SAB Biotherapeutics, Inc.

SABS

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001833214

SEC filings (opens in a new tab)

No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.

Other share classesSABSW

Q2 2026 vs. Q1 2026

How the institutions holding SAB Biotherapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of SABS: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Q2 2026	Change
Holders	76	87	+11
Shares	69.2M	68.4M	−793.8K (−1.1%)
Value	$265.0M	$266.8M	+$1.74M (+0.7%)

New holders (32)

Institutions that held SAB Biotherapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to SABS in Q2 2026
Institution	Shares	Value	% of portfolio
Susquehanna International Group, LLP	438,515	$1.71M	0.00%
DV Equities, LLC	400,000	$1.56M	0.23%
Polymer Capital Management (HK) LTD	306,581	$1.20M	0.12%
Vanguard Portfolio Management LLC	292,728	$1.14M	0.00%
Bank of New York Mellon Corp	107,847	$420.6K	0.00%
Charles Schwab Investment Management Inc	105,682	$412.2K	0.00%
Alps Advisors Inc	77,600	$302.6K	0.00%
Citadel Advisors LLC	62,797	$244.9K	0.00%
Nuveen, LLC	58,398	$227.8K	0.00%
Rhumbline Advisers	45,164	$176.1K	0.00%
Wells Fargo & Company	44,083	$171.9K	0.00%
Deutsche Bank AG	42,371	$165.2K	0.00%
IFP Advisors, Inc	38,699	$150.9K	0.00%
Price T Rowe Associates Inc	35,620	$139.0K	0.00%
MetLife Investment Management	28,015	$109.3K	0.00%
Alliancebernstein L.P.	26,970	$105.2K	0.00%
Invesco Ltd.	22,593	$88.1K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	19,996	$78.0K	0.00%
Jane Street Group, LLC	14,634	$57.1K	0.00%
Manufacturers Life Insurance Company, The	12,947	$50.5K	0.00%
New York State Common Retirement Fund	12,900	$50.3K	0.00%
Police & Firemen's Retirement System of New Jersey	12,807	$49.9K	0.00%
STRS Ohio	8,500	$33.1K	0.00%
Legal & General Group Plc	4,223	$16.5K	0.00%
Ameritas Investment Partners, Inc.	3,941	$15.4K	0.00%
Russell Investments Group, Ltd.	3,472	$13.5K	0.00%
Federation des caisses Desjardins du Quebec	2,000	$7.80K	0.00%
Group One Trading, L.P.	1,852	$7.22K	0.00%
Truvestments Capital LLC	1,100	$4.29K	0.00%
Sterling Capital Management LLC	875	$3.41K	0.00%
California State Teachers Retirement System	598	$2.33K	0.00%
FMR LLC	116	$452	0.00%

Sold out (21)

Institutions that held SAB Biotherapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of SABS in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Jefferies Financial Group Inc.	903,094	$3.46M
Blackstone Group Inc.	860,170	$3.29M
ExodusPoint Capital Management, LP	768,627	$2.94M
Monashee Investment Management LLC	500,000	$1.92M
Marshall Wace, LLP	463,925	$1.78M
DV Trading LLC	400,000	$1.53M
Seven Grand Managers, LLC	275,000	$1.05M
Brevan Howard Capital Management LP	59,161	$226.6K
Fifth Lane Capital, LP	46,500	$178.1K
Commonwealth Equity Services, LLC	46,455	$177.9K
Virtu Financial LLC	37,943	$145.0K
Prelude Capital Management, LLC	34,124	$130.7K
Omers Administration Corp	29,700	$113.8K
Qube Research & Technologies Ltd	24,098	$92.3K
Diametric Capital, LP	16,292	$62.4K
Hudson Bay Capital Management LP	16,100	$61.7K
Catalyst Funds Management Pty Ltd	15,100	$57.8K
Colony Group, LLC	14,036	$53.8K
State of Wyoming	7,899	$30.3K
Simplex Trading, LLC	4,713	$18.1K
MAI Capital Management	217	$832